Feighner Jp
Impact in
- Pharmacology top 5%
- Treatment of Major Depression
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
Papers in
- Pharmacology 11
- Treatment of Major Depression 11
-
- Electroconvulsive Therapy Studies 4
- Attention Deficit Hyperactivity Disorder 2
- Schizophrenia research and treatment 2
- Co-authors
- G. GORDON HENDRICKSON (1 shared paper)Cohn Jb (1 shared paper)Fieve Rr (1 shared paper)Dunner Dl (1 shared paper)Tony E. Walshe (1 shared paper)
- Journals
- Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (1 paper)PubMed (15 papers)
- Partner nations
- United States
In The Last Decade
Feighner Jp
16 papers receiving 404 citations
Peers
Comparison fields: 5 of 62
- Pharmacology 282
- Biological Psychiatry 38
- Psychiatry and Mental health 214
- Experimental and Cognitive Psychology 141
- Cellular and Molecular Neuroscience 74
Countries citing papers authored by Feighner Jp
This map shows the geographic impact of Feighner Jp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feighner Jp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feighner Jp more than expected).
Fields of papers citing papers by Feighner Jp
This network shows the impact of papers produced by Feighner Jp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feighner Jp. The network helps show where Feighner Jp may publish in the future.
Co-authors
The 5 scholars most cited alongside Feighner Jp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. | 1992 | 74 |
| 2 | A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder. | 1985 | 58 |
| 3 | A comparison of nefazodone, imipramine, and placebo in patients with moderate to severe depression. | 1989 | 57 |
| 4 | Buspirone in the long-term treatment of generalized anxiety disorder. | 1987 | 55 |
| 5 | The role of venlafaxine in rational antidepressant therapy. | 1994 | 51 |
| 6 | A fixed-dose (300 mg) efficacy study of bupropion and placebo in depressed outpatients. | 1990 | 51 |
| 7 | A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients. | 1984 | 24 |
| 8 | Long-term therapy for depression with trazodone. | 1983 | 19 |
| 9 | The use of bupropion in hospitalized depressed patients. | 1983 | 17 |
| 10 | Open label study of alprazolam in severely depressed inpatients. | 1983 | 11 |
| 11 | Benzodiazepines as antidepressants. A triazolobenzodiazepine used to treat depression. | 1982 | 8 |
| 12 | A review of controlled studies of adinazolam mesylate in patients with major depressive disorder. | 1986 | 8 |
| 13 | Pilot study of alpidem, a novel imidazopyridine compound, in anxiety. | 1988 | 5 |
| 14 | [Clinical effects of serotonin reuptake inhibitors--a review]. | 1994 | 2 |
| 15 | [Diagnosis criteria from the Saint Louis school (Missouri-USA)]. | 1978 | 1 |
| 16 | [Review of studies of trazodone at the Feighner Research Institute in ambulatory and hospitalized patients]. | 1986 | 1 |
About Feighner Jp
Feighner Jp is a scholar working on Pharmacology, Psychiatry and Mental health, Cognitive Neuroscience, Experimental and Cognitive Psychology and Pediatrics, Perinatology and Child Health, having authored 16 papers that have together received 442 indexed citations. Recurring topics across this work include Treatment of Major Depression (11 papers), Electroconvulsive Therapy Studies (4 papers), Attention Deficit Hyperactivity Disorder (2 papers), Pain Management and Placebo Effect (2 papers), Schizophrenia research and treatment (2 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers), Pharmaceutical studies and practices (1 paper) and Child and Adolescent Psychosocial and Emotional Development (1 paper). The work is most often cited by research in Pharmacology (282 citations), Biological Psychiatry (38 citations), Psychiatry and Mental health (214 citations), Experimental and Cognitive Psychology (141 citations) and Cellular and Molecular Neuroscience (74 citations). Feighner Jp has collaborated with scholars based in United States. Frequent co-authors include G. GORDON HENDRICKSON, Cohn Jb, Fieve Rr, Dunner Dl and Tony E. Walshe. Their work appears in journals such as Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.